Scientists have identified a key molecule - called USP13 - which may provide a new avenue to prevent the build up of alpha-synuclein in brain cells.
Results published today in the scientific journal Science Translational Medicine highlights a link between the removal of the appendix and a reduced risk of developing Parkinson's.
The UK-wide Predict PD study, funded by Parkinson's UK, is seeking 10,000 people aged 60-80 without Parkinson's to find clues to the very earliest stages of the condition.
The pharmaceutical company Biogen has presented promising initial results from trials testing a potential new treatment for Parkinson's which targets the alpha-synuclein protein.
A US study has found that people with Attention-Deficit Hyperactivity Disorder (ADHD) may have an increased risk of developing Parkinson's.
Researchers and drug companies have a new tool in the search for better treatments for Parkinson's - a brain scan that can be used to select the right people for clinical trials.
Researchers in America have developed an experimental drug, similar to compounds used to treat diabetes, that slows the progression of Parkinson's in a mouse model of the condition.